Magnesium Aspartate.

Magnesium-ATP runs the sodium-potassium pump and low magnesium status increases urinary potassium loss. Potassium magnesium aspartate pairs the two on one shared carrier.

The hydroxylation steps that convert vitamin D to 25(OH)D and then its active form both need magnesium-dependent enzymes. Higher vitamin D intake raises magnesium turnover.

B6 supports magnesium movement into cells and reduces loss, and it is also the cofactor for the transaminases that handle aspartate. It sits on both halves of this salt.

Calcium and magnesium overlap on intestinal transport, so a large single dose of one lowers uptake of the other. Spacing them keeps both.

High zinc doses worsen magnesium balance in mineral balance work. Separate dosing removes the overlap.

Thiamine pyrophosphate enzymes carry magnesium in the active site, so carbohydrate oxidation needs both. Thiamine performs only as well as magnesium status allows.

Creatine kinase acts on magnesium-ATP, so magnesium is part of the reaction creatine supports. Aspartate also feeds the malate-aspartate shuttle that moves reducing equivalents into mitochondria.

Aspartate donates a nitrogen to argininosuccinate in the urea cycle, the step that regenerates arginine. The two sit on the same nitrogen pathway.

Taurine acts as an intracellular osmolyte and influences calcium handling in excitable tissue, which overlaps with magnesium's role as a physiological calcium counterweight. The magnesium-taurate salt exists precisely because formulators wanted both in one molecule. Combining a magnesium salt with free taurine is the same idea assembled separately. No trial compares the assembled pair with the single salt.

Boron intake influences renal handling and retention of magnesium and calcium in balance studies. The direction reported is reduced urinary loss of magnesium when boron intake rises from a low baseline. That is a balance measurement, not a clinical outcome. The effect is described in low-intake states and should not be read as dose-responsive above them.

Vitamin K2 carboxylates osteocalcin and matrix Gla protein, the proteins that bind calcium in bone and restrain it elsewhere; magnesium is required for the enzymes that activate vitamin D, which drives calcium absorption in the first place. The three sit on one mineral-handling axis, which is why bone formulas carry them together. This describes normal mineral handling and not a bone condition. Whether the combination adds anything beyond the individual nutrients has not been isolated here.

Phosphate and magnesium form sparingly soluble complexes in the gut lumen, and high phosphate intake reduces magnesium absorption. The same chemistry underlies struvite formation, which is why phosphate shows up alongside magnesium in the co-study index. Separating a high-phosphate load from a magnesium dose is ordinary handling. The interaction is well described and does not need a combination trial.

Iron and magnesium are both divalent cations absorbed in the upper small intestine, and a large single dose of one reduces uptake of the other taken at the same time. The competition is dose-dependent and largely disappears when doses are spaced by a few hours. Most formulators split them across morning and evening for this reason. Nothing about this is specific to the aspartate salt.

Magnesium salts must dissolve into free ionic magnesium before they can be absorbed, and gastric acid does that work. Organic salts such as aspartate are already more soluble than oxide, so they depend on acidity less. Where gastric acidity is low, an acidifier in the same dose can improve dissolution of the less soluble salts more than the more soluble ones. Read this as dissolution chemistry, not an absorption figure.

An alkalising agent raises stomach pH and reduces the amount of free magnesium ion released from a salt in the same sitting. The two are also both used around exercise, so the timing clash is real rather than theoretical. Spacing them avoids the issue. The magnitude depends on the salt's intrinsic solubility.

Fermentation of inulin-type fructans lowers colonic pH and produces short-chain fatty acids, and human balance studies report increased magnesium and calcium absorption on that background. The measurements are absorption and retention markers rather than clinical outcomes. Effects are clearest in adolescents and in low-intake states. Gas and bloating limit the dose some people tolerate.

Resistant starch reaches the colon undigested and is fermented to short-chain fatty acids, acidifying the lumen and keeping magnesium in a soluble ionic form for longer. The mechanism is the same one described for fructans. Human magnesium balance data are thinner for resistant starch than for inulin. This is a mechanistic pairing.

Phytate in cereals and legumes chelates magnesium in the gut lumen and reduces its availability. Phytase hydrolyses phytate and releases the bound mineral. This is why phytase is standard in animal feed formulation for mineral availability. It is an established chemical relationship rather than a supplement combination trial.

Manganese and magnesium share divalent metal transport routes and manganese can substitute for magnesium at some enzyme sites in vitro. Large doses of one taken with the other reduce uptake of the second. Ordinary supplemental amounts of manganese are small enough that the practical effect is limited. Say it as competition at the transporter and not as a deficiency claim.

Magnesium salts and melatonin appear together in evening formulas because both are associated with settling before sleep. Magnesium's contribution runs through NMDA receptor and GABA-A modulation; melatonin acts on its own receptors on the circadian side. The pairing is formulation convention with mechanistic overlap rather than a tested combination. Anyone taking other calming agents should account for the stacking.

Both glycine and aspartate are used as amino acid ligands for magnesium, giving a chelate that stays soluble across a wider pH range than the oxide. The ligand contributes its own properties: aspartate is a dicarboxylic acid used in the malate-aspartate shuttle, glycine is an inhibitory neurotransmitter in the spinal cord. The chelation chemistry is settled; the two ligands are different choices, not a ranking. Elemental magnesium per gram is lower in any amino acid chelate than in the oxide because the ligand carries mass.

Riboflavin is phosphorylated to FMN and adenylylated to FAD by kinases that require magnesium-ATP. Without adequate magnesium the conversion of the vitamin into its working coenzyme forms slows. This is a textbook cofactor relationship. It says nothing about the size of any effect at supplemental doses.

Selenocysteine incorporation depends on ATP-driven and GTP-driven steps, and every nucleotide triphosphate in the cell works as a magnesium complex. The dependency is general to protein synthesis rather than specific to selenium. Read it as background biochemistry supporting normal antioxidant enzyme production. No combination data are described here.